X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (61) 61
particle physics (60) 60
physical sciences (59) 59
fysik (58) 58
natural sciences (58) 58
naturvetenskap (58) 58
high energy physics - experiment (55) 55
physics (55) 55
physics - high energy physics - experiment (55) 55
high energy physics (46) 46
physics, particles & fields (46) 46
physics of elementary particles and fields (44) 44
humans (34) 34
detectors (28) 28
index medicus (26) 26
phenomenology (26) 26
female (23) 23
collisions (22) 22
male (22) 22
astronomy & astrophysics (21) 21
elementary particles, quantum field theory (21) 21
quantum field theories, string theory (21) 21
aged (17) 17
nuclear experiment (17) 17
astronomy, astrophysics and cosmology (16) 16
middle aged (16) 16
analysis (14) 14
decay (13) 13
measurement science and instrumentation (13) 13
nuclear energy (13) 13
nuclear physics, heavy ions, hadrons (13) 13
animals (12) 12
large hadron collider (12) 12
luminosity (12) 12
model (12) 12
parton distributions (12) 12
physics, nuclear (12) 12
immunology (11) 11
adult (10) 10
astrophysics (10) 10
high energy astrophysical phenomena (10) 10
oncology (10) 10
subatomic physics (10) 10
subatomär fysik (10) 10
hadron-hadron scattering (9) 9
lhc (9) 9
searching (9) 9
classical and quantum gravitation, relativity theory (8) 8
higgs bosons (8) 8
instrumentation and detectors (8) 8
metastasis (8) 8
particle physics - experiment (8) 8
quantum physics (8) 8
standard model (8) 8
cancer (7) 7
colliders (7) 7
cross sections (7) 7
hadrons (7) 7
health aspects (7) 7
instruments & instrumentation (7) 7
internal medicine (7) 7
measurement (7) 7
medicine & public health (7) 7
mice (7) 7
particle collisions (7) 7
pathology (7) 7
protons (7) 7
transverse momentum (7) 7
aged, 80 and over (6) 6
care and treatment (6) 6
hadron colliders (6) 6
hematology (6) 6
instrumentation (6) 6
jets (6) 6
leptons (6) 6
lung cancer (6) 6
medicine (6) 6
multidisciplinary sciences (6) 6
patients (6) 6
prognosis (6) 6
supergauge transformations (6) 6
tumors (6) 6
apoptosis (5) 5
bosons (5) 5
broken symmetries (5) 5
cell biology (5) 5
ciências físicas [ciências naturais] (5) 5
computer simulation (5) 5
confidence intervals (5) 5
electrons (5) 5
engineering (5) 5
immunohistochemistry (5) 5
immunotherapy (5) 5
interferon (5) 5
kinases (5) 5
lead (5) 5
ligands (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - drug therapy (5) 5
lung neoplasms - pathology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 29 - 39
Summary Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability... 
Internal Medicine | ANAPLASTIC LYMPHOMA KINASE | MEDICINE, GENERAL & INTERNAL | SAFETY | CH5424802 | AF-001JP | ADVANCED NSCLC | INHIBITORS | CHEMOTHERAPY | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Medical services | Metastasis | Kinases | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Cut-off | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals
Journal Article
Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 7, pp. 951 - 959
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Chengshui and Chen, Yen-Hsun and Chen, Yuan and Chen, Yuanbin and Chen, Zhendong and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Nataliia and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Li, Chien-Te and Liang, Zongan and Lin, Zhong and Ma, Shenglin and Ma, Rui and Nan, Kejun and Shu, Yongqian and Wang, Chin-Chou and Wang, Kai and Wang, Mengzhao and Wu, Gang and Wu, Shang-Yin and Yang, Nong and Yang, Zhixiong and Zhang, Wei and Zhang, Helong and Zhao, Yanqiu and Zhao, Jun and Zhou, Jianying and Zhou, Caicun and Zhou, Xiangdong and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and ... and CASPIAN Investigators and CASPIAN investigators
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
PROPHYLACTIC CRANIAL IRRADIATION | SCLC | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CISPLATIN | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols | Carboplatin - administration & dosage | Etoposide - administration & dosage | Male | Small Cell Lung Carcinoma - drug therapy | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Cisplatin - adverse effects | Female | Small Cell Lung Carcinoma - mortality | Aged | Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article
Journal Article
European Physical Journal C, ISSN 1434-6044, 2011, Volume 71, Issue 11, pp. 1 - 27
Journal Article
by Aad, G and Abajyan, T and Abbott, B and Abdallah, J and Abdel Khalek, S and Abdelalim, A.A and Abdinov, O and Aben, R and Abi, B and Abolins, M and AbouZeid, O.S and Abramowicz, H and Abreu, H and Acharya, B.S and Adamczyk, L and Adams, D.L and Addy, T.N and Adelman, J and Adomeit, S and Adragna, P and Adye, T and Aefsky, S and Aguilar-Saavedra, J.A and Agustoni, M and Aharrouche, M and Ahlen, S.P and Ahles, F and Ahmad, A and Ahsan, M and Aielli, G and Akdogan, T and Åkesson, T.P.A and Akimoto, G and Akimov, A.V and Alam, M.A and Alam, M.S and Albert, J and Albrand, S and Aleksa, M and Aleksandrov, I.N and Alessandria, F and Alexa, C and Alexander, G and Alexandre, G and Alexopoulos, T and Alhroob, M and Aliev, M and Alimonti, G and Alison, J and Allbrooke, B.M.M and Allport, P.P and Allwood-Spiers, S.E and Almond, J and Aloisio, A and Alon, R and Alonso, F and Alonso, A and Altheimer, A and Alvarez Gonzalez, B and Alviggi, M.G and Amako, K and Amelung, C and Ammosov, V.V and Amor Dos Santos, S.P and Amorim, A and Amram, N and Anastopoulos, C and Ancu, L.S and Andari, N and Andeen, T and Anders, C.F and Anders, G and Anderson, K.J and Andreazza, A and Andrei, V and Andrieux, M.-L and Anduaga, X.S and Angelidakis, S and Anger, P and Angerami, A and Anghinolfi, F and Anisenkov, A and Anjos, N and Annovi, A and Antonaki, A and Antonelli, M and Antonov, A and Antos, J and Anulli, F and Aoki, M and Aoun, S and Aperio Bella, L and Apolle, R and Arabidze, G and Aracena, I and Arai, Y and Arce, A.T.H and Arfaoui, S and Arguin, J.-F and Arik, M and ... and ATLAS Collaboration and BROOKHAVEN NATIONAL LABORATORY (BNL) and Partikel- och astropartikelfysik and Skolan för teknikvetenskap (SCI) and KTH and Fysik
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 1 - 29
Journal Article